Hong Kong-based Prenetics Group is set to go public on the Nasdaq through a merger with a special purpose acquisition company, Artisan Acquisition Corp., in a deal that values the Covid-19 testing firm at $1.25bn. The combined entity value is estimated to be nearly $1.7bn. In addition to rapid diagnostics for Covid-19, Prenetics focuses on genomic testing and tests for other infectious diseases. The company recently introduced a CE-IVD point-of-care diagnostics and at-home rapid detection health monitoring system for Covid-19. It also offers a laboratory PCR testing solution for the disease, with over five million tests conducted so far.
iGene Laboratory has donated 25,000 SARS-CoV-2 PCR Kits to Indonesia to help the country’s government manage the ongoing Covid-19 pandemic. These kits will be immediately rolled out at the Gatot Soebroto Army Hospital and Dr. Esnawan Hospital in Indonesia. iGene provides a pre-departure test service for Covid-19, where travellers can take a PCR test and obtain digital results.
Dotz Nano has signed a distribution agreement and secured a $220,000 purchase order from Paraguay-based El Alamo to supply its SARS-CoV-2 virus detection technology in the country. Initially, the deal provides El Alamo with the right to sell the Dotz Test Kits in Paraguay for two years with conditional exclusivity. In the country, Dotz holds CE Mark and a Certificate of Free Sale for its nasopharyngeal swab as well as saliva-based test kits.
